help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nardulli, A. M.
Right arrow Articles by Katzenellenbogen, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nardulli, A. M.
Right arrow Articles by Katzenellenbogen, B. S.

Endocrinology, Vol 122, 1532-1540, Copyright © 1988 by Endocrine Society


ARTICLES

Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin

AM Nardulli and BS Katzenellenbogen
Department of Physiology and Biophysics, University of Illinois, Urbana 61801.

We have examined the effect of progestin on the regulation of cellular progesterone receptor (PR) levels and have used dense amino acid- density shift experiments to determine the mechanism by which progestin markedly decreases PR. We have utilized T47D human breast cancer cells which contain high levels of PR and are progestin responsive. When these cells are exposed to the progestin R5020, there is a time- and concentration-dependent decrease in PR levels. Experiments with different concentrations of R5020 reveal that the rate and extent of PR decrease reflect the time course of receptor occupancy and the fractional saturation of receptor. With a high concentration of ligand (20 nM) that labels all receptors rapidly, reductions in PR levels (processing) occur immediately and proceed rapidly to levels that are 15-20% of the initial; at lower concentrations (5 nM), where it takes several hours to achieve full saturation of receptors, there is a delay before the maximal rate of processing develops and then continues to achieve final receptor levels that are 15-20% of the initial; with a low concentration of ligand (0.5 nM), binding is even slower and never reaches full receptor saturation, with the consequence that processing is not only delayed but also less complete. Immunochemical detection of PR with a monoclonal antibody (B39) reveals a good correspondence between the loss of immunoreactive and hormone binding PR, and analysis of the A (Mr 85,000) and B (Mr 115,000) receptor forms on Western blots demonstrates that both A and B receptor forms are reduced after exposure to R5020. Density labeling of PR by biosynthetic incorporation of 2H, 13C, 15N (dense) amino acids reveals that PR turns over with a half-life of 21 h in control cells. In cells exposed to 20 nM R5020, PR levels decline and receptor half-life is reduced to 6 h. In addition, there is also a time-dependent decrease in the rate constant of PR synthesis, k8, which decreases to less than 10% of its initial value after 24 h of R5020 exposure. Thus, the R5020-evoked reduction in PR levels in this progestin-sensitive cell line is due both to a marked increase in the rate of receptor degradation as well as a dramatic decrease in the rate of receptor synthesis.


This article has been cited by other articles:


Home page
EndocrinologyHome page
A. Samalecos and B. Gellersen
Systematic Expression Analysis and Antibody Screening Do Not Support the Existence of Naturally Occurring Progesterone Receptor (PR)-C, PR-M, or Other Truncated PR Isoforms
Endocrinology, November 1, 2008; 149(11): 5872 - 5887.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W.-Y. Chen, J.-H. Weng, C.-C. Huang, and B.-c. Chung
Histone Deacetylase Inhibitors Reduce Steroidogenesis through SCF-Mediated Ubiquitination and Degradation of Steroidogenic Factor 1 (NR5A1)
Mol. Cell. Biol., October 15, 2007; 27(20): 7284 - 7290.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E. T. Alarid
Lives and Times of Nuclear Receptors
Mol. Endocrinol., September 1, 2006; 20(9): 1972 - 1981.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. C. Condon, D. B. Hardy, K. Kovaric, and C. R. Mendelson
Up-Regulation of the Progesterone Receptor (PR)-C Isoform in Laboring Myometrium by Activation of Nuclear Factor-{kappa}B May Contribute to the Onset of Labor through Inhibition of PR Function
Mol. Endocrinol., April 1, 2006; 20(4): 764 - 775.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. K. Pierson-Mullany and C. A. Lange
Phosphorylation of Progesterone Receptor Serine 400 Mediates Ligand-Independent Transcriptional Activity in Response to Activation of Cyclin-Dependent Protein Kinase 2
Mol. Cell. Biol., December 15, 2004; 24(24): 10542 - 10557.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. A. Lange
Making Sense of Cross-Talk between Steroid Hormone Receptors and Intracellular Signaling Pathways: Who Will Have the Last Word?
Mol. Endocrinol., February 1, 2004; 18(2): 269 - 278.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. U. Agoulnik, W. C. Krause, W. E. Bingman III, H. T. Rahman, M. Amrikachi, G. E. Ayala, and N. L. Weigel
Repressors of Androgen and Progesterone Receptor Action
J. Biol. Chem., August 15, 2003; 278(33): 31136 - 31148.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. L. Grimm, T. N. Seagroves, E. B. Kabotyanski, R. C. Hovey, B. K. Vonderhaar, J. P. Lydon, K. Miyoshi, L. Hennighausen, C. J. Ormandy, A. V. Lee, et al.
Disruption of Steroid and Prolactin Receptor Patterning in the Mammary Gland Correlates with a Block in Lobuloalveolar Development
Mol. Endocrinol., December 1, 2002; 16(12): 2675 - 2691.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. Takamoto, B. Zhao, S. Y. Tsai, and F. J. DeMayo
Identification of Indian Hedgehog as a Progesterone-Responsive Gene in the Murine Uterus
Mol. Endocrinol., October 1, 2002; 16(10): 2338 - 2348.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. He, N. T. Bowen, J. T. Minges, and E. M. Wilson
Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 Coactivator Recruitment by Activation Function 2
J. Biol. Chem., November 2, 2001; 276(45): 42293 - 42301.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Shen, K. B. Horwitz, and C. A. Lange
Transcriptional Hyperactivity of Human Progesterone Receptors Is Coupled to Their Ligand-Dependent Down-Regulation by Mitogen-Activated Protein Kinase-Dependent Phosphorylation of Serine 294
Mol. Cell. Biol., September 15, 2001; 21(18): 6122 - 6131.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. L. Turgeon and D. W. Waring
Progesterone Regulation of the Progesterone Receptor in Rat Gonadotropes
Endocrinology, September 1, 2000; 141(9): 3422 - 3429.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. A. Lange, T. Shen, and K. B. Horwitz
Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome
PNAS, February 1, 2000; 97(3): 1032 - 1037.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. L. Turgeon, S. M. Van Patten, G. Shyamala, and D. W. Waring
Steroid Regulation of Progesterone Receptor Expression in Cultured Rat Gonadotropes
Endocrinology, May 1, 1999; 140(5): 2318 - 2325.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
J. D. Graham and C. L. Clarke
Physiological Action of Progesterone in Target Tissues
Endocr. Rev., August 1, 1997; 18(4): 502 - 519.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society